Botswana vs Eswatini: Hepatitis B surface antigen (HBsAg) prevalence
Botswana
1.1%
in 2024
Eswatini
1.2%
in 2024
Botswana rank
26th
Eswatini rank
25th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Botswana
- Eswatini
How they compare
Eswatini currently reports 1.2% against 1.1% in Botswana, a difference of 0.1%.
That makes Eswatini's figure about 1.1 times Botswana's.
Across all 10 years both countries report, Eswatini has been ahead every year.
Botswana ranks 26th and Eswatini ranks 25th of 194 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Botswana | Eswatini | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.5% | 0.1% | Eswatini |
| 2020s | 1.2% | 1.4% | 0.2% | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Botswana or Eswatini?
- Eswatini, at 1.2% against 1.1% in Botswana as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Botswana and Eswatini?
- 0.1%, with Eswatini ahead.
- How many years of comparable data are there for Botswana and Eswatini?
- 10 years are reported by both, from 2015 to 2024.
- How do Botswana and Eswatini rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Botswana ranks 26th and Eswatini ranks 25th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.